Literature DB >> 19969317

Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003.

Jun Okada1, Nobuko Ohshima, Ritsuko Kubota-Koketsu, Sayuri Ota, Wakana Takase, Masachika Azuma, Yoshitaka Iba, Naoko Nakagawa, Tetsushi Yoshikawa, Youichi Nakajima, Toyokazu Ishikawa, Yoshizo Asano, Yoshinobu Okuno, Yoshikazu Kurosawa.   

Abstract

We tried to reveal the strain specificity of neutralizing mAbs against H3N2 influenza viruses in individuals. A large number of B lymphocytes of a pediatrician were collected by apheresis and two Ab libraries were constructed at 2004 and 2007 by using the phage-display technology. The libraries were screened against 12 different H3 strains of flu isolated between 1968 and 2004. Large numbers of clones that bound to the Ags were isolated and mAbs that specifically bound to H3 strain viruses were selected. Their binding activity to the 12 strains and neutralizing activity were studied by ELISA and focus reduction test, respectively. Furthermore, the binding activity to hemagglutinin (HA) was examined by Western blot. The majority of clones showing the neutralizing activity turned out to be anti-HA mAbs and could be divided into three major groups showing distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19969317     DOI: 10.1016/j.virol.2009.11.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5.

Authors:  Nobuko Ohshima; Yoshitaka Iba; Ritsuko Kubota-Koketsu; Yoshizo Asano; Yoshinobu Okuno; Yoshikazu Kurosawa
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

2.  Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

Authors:  Gayathri Bommakanti; Michael P Citron; Robert W Hepler; Cheryl Callahan; Gwendolyn J Heidecker; Tariq Ahmad Najar; Xianghan Lu; Joseph G Joyce; John W Shiver; Danilo R Casimiro; Jan ter Meulen; Xiaoping Liang; Raghavan Varadarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

3.  Analysis of antigenically important residues in human influenza A virus in terms of B-cell epitopes.

Authors:  William D Lees; David S Moss; Adrian J Shepherd
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.

Authors:  Yoshitaka Iba; Yoshifumi Fujii; Nobuko Ohshima; Tomomi Sumida; Ritsuko Kubota-Koketsu; Mariko Ikeda; Motoaki Wakiyama; Mikako Shirouzu; Jun Okada; Yoshinobu Okuno; Yoshikazu Kurosawa; Shigeyuki Yokoyama
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

5.  Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Randy Albrecht; David L Blum; Irene Ramos; Ana Fernandez-Sesma; Kathryn M Edwards; Adolfo García-Sastre; Christopher F Basler; James E Crowe
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

6.  Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.

Authors:  Feng Liu; Vic Veguilla; F Liaini Gross; Eric Gillis; Thomas Rowe; Xiyan Xu; Terrence M Tumpey; Jacqueline M Katz; Min Z Levine; Xiuhua Lu
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

Review 7.  Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA.

Authors:  Jean-Philippe Julien; Peter S Lee; Ian A Wilson
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

8.  Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human.

Authors:  Seiya Yamayoshi; Mutsumi Ito; Ryuta Uraki; Tadahiro Sasaki; Kazuyoshi Ikuta; Yoshihiro Kawaoka
Journal:  J Infect       Date:  2017-12-14       Impact factor: 6.072

9.  Viral receptor-binding site antibodies with diverse germline origins.

Authors:  Aaron G Schmidt; Matthew D Therkelsen; Shaun Stewart; Thomas B Kepler; Hua-Xin Liao; M Anthony Moody; Barton F Haynes; Stephen C Harrison
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

10.  Focused antibody response to influenza linked to antigenic drift.

Authors:  Kuan-Ying A Huang; Pramila Rijal; Lisa Schimanski; Timothy J Powell; Tzou-Yien Lin; John W McCauley; Rodney S Daniels; Alain R Townsend
Journal:  J Clin Invest       Date:  2015-05-26       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.